Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.288NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.249NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.378NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.97NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.439NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.408NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.256NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.128NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.36.33NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.405NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.296NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.412NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.421NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.364NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.82NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.61NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FQ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21359South Korea
JB.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.3.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FZ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.7.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.30.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.68NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CD.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.122.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.43.6 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBF.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.43.9 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XUNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.3 (Omicron)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.16.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.372NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.47NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.38NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.251NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.256NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.77NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.34NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.248NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21305.4South Korea
B.32NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used